We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
-23.53%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$180M
AUM Growth
-$142M
(-44%)
Cap. Flow
-$50.1M
Cap. Flow
% of AUM
-27.76%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
VTYX
Ventyx Biosciences
VTYX
|
+$45.2M |
| 2 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
+$4.71M |
| 3 |
Pharvaris
PHVS
|
+$160K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTYX
1
DELISTED
Ventyx Biosciences
VTYX
| $77M | 42.68% |
2,298,833
-1,162,703
| -34% | -$45.2M |
|
2
ALX Oncology
ALXO
$279M
| $43.8M | 24.3% |
9,699,925
| – | – |
|
3
Harmony Biosciences
HRMY
$1.94B
| $33.8M | 18.74% |
1,035,396
| – | – |
|
|
4
Pharvaris
PHVS
$2.35B
| $18.4M | 10.17% |
2,278,575
-18,135
| -0.8% | -$160K |
|
|
IMPL
5
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
| $3.86M | 2.14% |
2,759,791
| – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $3.55M | 1.97% |
1,866,339
| – | – |
|
|
CINC
7
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| – | – |
-383,390
| Closed | -$4.71M |
|
Similar funds
OCWP
FFP
BDA
PHC
OFCM
SA
ACC
NRCM